montelukast sodium (Camber Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the montelukast sodium drug offered from Camber Pharmaceuticals, Inc.. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Camber Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: montelukast sodium
SUBSTANCE NAME: MONTELUKAST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-05-27
END MARKETING DATE: 0000-00-00


montelukast sodium HUMAN PRESCRIPTION DRUG Details:

Item Descriptionmontelukast sodium from Camber Pharmaceuticals, Inc.
LABELER NAME: Camber Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4(mg/1)
START MARKETING DATE: 2015-05-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 31722-727_cd08fa68-33ec-4627-b399-03d038cc00c2
PRODUCT NDC: 31722-727
APPLICATION NUMBER: ANDA204093

Other MONTELUKAST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Camber Pharmaceuticals, Inc.montelukast sodium
Macleods Pharmaceuticals LimitedMontelukast sodium